SEC Form 4 · accession 0001209191-18-049429
FIVE PRIME THERAPEUTICS INC · FPRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Bryan Irving
Officer — EVP, Chief Scientific Officer
Period of report
Sep 1, 2018
Accepted (ET)
Sep 5, 2018 · 11:24 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001175505
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 1, 2018 | F | 2,479 | $14.00 | D | 22,271 | D |
Table II — derivative securities
No Table II lines on this filing.